Sinopharm Says Second Covid Vaccine Found to Be Safe
Photographer: Xinhua News Agency via Getty Images
This article is for subscribers only.
The second vaccine developed by Sinopharm has been found to be safe and able to generate high titers of antibodies among participants in phase I and II clinical trials, according to a Weibo posting by Sinopharm Group on Sunday.